MAPS Public Benefit Corp. closed a $100 million Series A funding round and rebranded as Lykos Therapeutics, the company announced Thursday. The funding, which will support the company’s development of MDMA-assisted therapy for post-traumatic stress disorder, comes from a range of new investors, alongside the conversion of an undisclosed sum …

The new law states, “It is unlawful for an employer to discriminate against a person in the initial hiring for employment if the discrimination is based upon the person’s use of cannabis off the job and away from the workplace.” The post Washington: New State Law Takes Effect Barring Pre-Employment Marijuana Testing for Most Employees appeared first on NORML.

Yet another turbulent but victory-filled 12 months for many in the cannabis trade is behind us, and plenty of business leaders are ready to focus on 2024. “The forthcoming year will be the most exciting ever in the industry,” said Morgan Paxhia, co-founder and managing director of Poseidon Investment Management. …